Last verified: today
Ashitaba
Also known as: Angelica keiskei, Tomorrow's Leaf, Ashitaba Chalcone, 4-hydroxyderricin, xanthoangelol
Evidence under review. — Not yet rated
Japanese plant with early evidence for reducing belly fat and protecting muscle. Most research is in animals.
-
What it does
Ashitaba is a Japanese plant (Angelica keiskei) whose yellow sap contains unique compounds called chalcones — primarily 4-hydroxyderricin and xanthoangelol. One small human trial found that 16 mg...
-
Evidence quality
Evidence base hasn't been formally rated yet. See research below.
-
Clinical dose
16 mg chalcone extract daily (clinical trial dose); No established dose for other uses
What the Science Says
Ashitaba is a Japanese plant (Angelica keiskei) whose yellow sap contains unique compounds called chalcones — primarily 4-hydroxyderricin and xanthoangelol. One small human trial found that 16 mg of ashitaba chalcone daily for 12 weeks significantly reduced visceral (belly) fat compared to placebo in overweight adults. Animal and cell studies also suggest it may help prevent steroid-induced muscle loss and support healthy cholesterol and blood sugar levels, though these effects have not been confirmed in human trials.
What It Doesn't Do
Not proven to treat multiple sclerosis or any neurological disease in humans — that research is only in mice. No human evidence it builds muscle or prevents muscle loss outside of steroid use. Don't expect dramatic weight loss — the human trial was small and only measured belly fat. Not a proven cholesterol drug replacement.
Evidence-Based Benefits
16 mg of ashitaba chalcone daily reduced belly fat in overweight adults after 12 weeks.
Weak EvidenceEffective at: 16 mg chalcone extract daily
Supporting studies (click to view on PubMed):
Ashitaba chalcones blocked steroid-induced muscle breakdown in cell and animal models.
Weak EvidenceEffective at: No established human dose
Supporting studies (click to view on PubMed):
Ashitaba extract reduced body fat and improved cholesterol and blood sugar in high-fat-diet mice.
Weak EvidenceEffective at: No established human dose
Supporting studies (click to view on PubMed):
Absorption & Bioavailability
Unknown — no human pharmacokinetic data in the provided studies. Light exposure can alter the chalcone compounds (isomerization), which may affect potency.
Red Flags to Watch For
- Only one small human clinical trial (42 participants) exists in the provided evidence — results need replication in larger studies
- High-dose animal studies showed kidney changes (alpha 2-urinary globulin nephropathy) in male rats — long-term human safety at high doses is unclear
- EFSA reviewed ashitaba sap as a 'novel food,' meaning regulatory safety data is still being established in Europe
- Most exciting claims (neuroprotection, cholesterol lowering) are based solely on animal or cell studies — not human trials
- 41 registered supplement products exist despite very limited clinical evidence — marketing likely outpaces the science
Frequently Asked Questions
What does Ashitaba do?
Japanese plant with early evidence for reducing belly fat and protecting muscle. Most research is in animals.
What is the effective dose of Ashitaba?
16 mg chalcone extract daily (clinical trial dose); No established dose for other uses
Is Ashitaba safe?
Only one small human clinical trial (42 participants) exists in the provided evidence — results need replication in larger studies
What doesn't Ashitaba do?
Not proven to treat multiple sclerosis or any neurological disease in humans — that research is only in mice.
Research Sources
- PubMed
- NIH DSLD
This information is for educational purposes only and is not medical advice. Always consult a healthcare professional before starting any supplement regimen. Last updated: 2026-11-16